Xilio Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 05/13/2025 | 9.11 M | $6.60 M | 0.00% | 12.19% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 05/15/2025 | 4.57 M | $3.31 M | 0.00% | 6.11% |
| MORGAN STANLEY | 05/15/2025 | 1.16 M | $837.29 K | 15.43% | 1.55% |
| VANGUARD GROUP INC | 05/09/2025 | 1.14 M | $822.26 K | 25.84% | 1.52% |
| FMR LLC | 05/12/2025 | 884.04 K | $640.40 K | -36.67% | 1.18% |
| AJU IB INVESTMENT CO., LTD. | 04/08/2025 | 667.74 K | $483.71 K | 0.00% | 0.89% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 379.02 K | $274.59 K | 5.75% | 0.51% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2025 | 254.35 K | $184.25 K | -25.90% | 0.34% |
| TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 05/15/2025 | 249.64 K | $180.74 K | 0.00% | 0.33% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 177.70 K | $128.73 K | -40.09% | 0.24% |
| UBS GROUP AG | 05/13/2025 | 163.10 K | $118.09 K | -34.60% | 0.22% |
| AVANTAX PLANNING PARTNERS, INC. | 04/29/2025 | 150.40 K | $108.95 K | 100.00% | 0.20% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 84.07 K | $60.90 K | 676.68% | 0.11% |
| BLACKROCK, INC. | 05/02/2025 | 74.70 K | $54.11 K | -1.82% | 0.10% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 71.08 K | $51.49 K | 0.00% | 0.10% |
| NORTHERN TRUST CORP | 05/13/2025 | 66.61 K | $48.25 K | 69.89% | 0.09% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 51.11 K | $37.02 K | 100.00% | 0.07% |
| SEVENBRIDGE FINANCIAL GROUP, LLC | 05/13/2025 | 46.00 K | $33.63 K | 12.20% | 0.06% |
| APTUS CAPITAL ADVISORS, LLC | 05/13/2025 | 46.00 K | $33.32 K | 12.20% | 0.06% |
| STATE STREET CORP | 05/15/2025 | 43.39 K | $31.43 K | 0.00% | 0.06% |
| SCIENTECH RESEARCH LLC | 05/15/2025 | 42.55 K | $30.82 K | 100.00% | 0.06% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 40.00 K | $28.98 K | 100.00% | 0.05% |
| RAYMOND JAMES FINANCIAL INC | 05/13/2025 | 33.96 K | $24.60 K | -32.19% | 0.05% |
| MARINER, LLC | 05/15/2025 | 25.00 K | $18.11 K | 0.00% | 0.03% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 05/13/2025 | 20.00 K | $14.49 K | 0.00% | 0.03% |
| DUNHILL FINANCIAL, LLC | 04/21/2025 | 10.27 K | $7.44 K | 100.00% | 0.01% |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 04/29/2025 | 10.00 K | $7.24 K | 100.00% | 0.01% |
| PINNACLE FINANCIAL GROUP, LLC / IL | 05/15/2025 | 10.00 K | $7.24 K | 0.00% | 0.01% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 05/15/2025 | 3.30 K | $2.39 K | 0.00% | 0.00% |
| KEY FINANCIAL INC | 05/01/2025 | 830 | $601 | 0.00% | 0.00% |
| PRIVATE WEALTH MANAGEMENT GROUP, LLC | 05/02/2025 | 310 | $225 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 290 | $210 | 9.43% | 0.00% |
| JPMORGAN CHASE & CO | 05/12/2025 | 62 | $45 | -6.06% | 0.00% |
| FIL LTD | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 05/08/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Xilio Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 41 institutional investors and hedge funds held shares of Xilio Therapeutics, Inc.. The most heavily invested institutionals were:
GILEAD SCIENCES, INC.: 9.11 M
Bain Capital Life Sciences Investors, LLC: 4.57 M
MORGAN STANLEY: 1.16 M
VANGUARD GROUP INC: 1.14 M
FMR LLC: 884,035
GEODE CAPITAL MANAGEMENT, LLC: 379,016
26.20% of Xilio Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 20.44 M shares in the last 24 months. This purchase volume represents approximately $14.10 M in transactions.